Copyright: ©Author(s) 2026.
World J Hepatol. Oct 27, 2026; 18(10): 123267
Published online Oct 27, 2026. doi: 10.4254/wjh.123267
Published online Oct 27, 2026. doi: 10.4254/wjh.123267
Table 4 Comparison of follow-up results between patients with hyperthyroidism-induced liver injury with antithyroid drug exposure and those without antithyroid drug exposure, n (%)/median (interquartile range)
| Items | Total | ATD (-) | ATD (+) | P value |
| Follow up for 1 year | n = 140 | n = 40 | n = 100 | |
| Death | 6 (4.28) | 4 (10.00) | 2 (2.00) | 0.005 |
| Number of hospitalizations in the past year | 1 (0, 2) | 2 (1, 3) | 1 (0, 2) | 0.024 |
| Follow up for 2 years | n = 134 | n = 36 | n = 98 | |
| Death | 7 (5.22) | 4 (11.11) | 3 (3.06) | 0.005 |
| Number of hospitalizations in the past year | 1 (0, 2) | 2 (1, 3) | 1 (0, 2) | 0.026 |
| Follow up for 3 years | n = 127 | n = 32 | n = 95 | |
| Death | 6 (4.72) | 3 (9.37) | 3 (3.15) | 0.008 |
| Number of hospitalizations in the past year | 1 (0, 2) | 2 (1, 3) | 1 (0, 2) | 0.031 |
- Citation: Yu W, Dai ZS, Li YH, Li MP, Li J, Jiao KX, Ma J, Li Y. Proactive antithyroid therapy improves survival in hyperthyroidism-induced liver injury: A real-world cohort study. World J Hepatol 2026; 18(10): 123267
- URL: https://www.wjgnet.com/1948-5182/full/v18/i10/123267.htm
- DOI: https://dx.doi.org/10.4254/wjh.123267